A Policy Perspective on the Global Use of Smokeless Tobacco

被引:25
作者
Siddiqi K. [1 ]
Vidyasagaran A.L. [1 ]
Readshaw A. [1 ]
Croucher R. [2 ]
机构
[1] Department of Health Sciences, The University of York
[2] Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London
基金
英国医学研究理事会;
关键词
Global health; Smokeless tobacco; Snus; Tobacco control;
D O I
10.1007/s40429-017-0166-7
中图分类号
学科分类号
摘要
Background: Globally, over 300 million people consume diverse smokeless tobacco (ST) products. They are addictive, cause cancer, increased cardiovascular mortality risks and poor pregnancy outcomes. Purpose of Review: To identify gaps in implementing key ST demand-reduction measures, focused literature reviews were conducted and findings synthesized according to relevant WHO Framework Convention on Tobacco Control (FCTC) Articles. Recent Findings: The literature supports implementation of ST demand-reduction measures. For taxation, labelling and packaging, most administrations have weaker policies for ST than cigarettes. Capacity to regulate ST contents and offer cessation support is lacking. There is poor compliance with bans on ST advertising, promotion and sponsorship. Summary: The literature on implementation of WHO FCTC for ST is limited. Although strengths of ST demand-control activities are currently identifiable from available literature, full implementation of FCTC is lacking. A wider evidence-based response to WHO FCTC is proposed, particularly for countries facing the greatest disease burdens. © 2017, The Author(s).
引用
收藏
页码:503 / 510
页数:7
相关论文
共 69 条
[1]  
Siddiqi K., Shah S., Abbas S.M., Vidyasagaran A., Jawad M., Dogar O., Et al., Global burden of disease due to smokeless tobacco consumption in adults: Analysis of data from 113 countries, BMC Med, 13, (2015)
[2]  
Sinha D.N., Gupta P.C., Ray C., Singh P.K., Prevalence of smokeless tobacco use among adults in WHO South-East Asia, Indian J Cancer, 49, 4, pp. 342-346, (2012)
[3]  
Stanfill S.B., Connolly G.N., Zhang L., Jia L.T., Henningfield J.E., Richter P., Et al., Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines, Tob Control, 20, 3, (2011)
[4]  
Sinha D.N., Suliankatchi R.A., Gupta P.C., Thamarangsi T., Agarwal N., Parascandola M., Et al., Global burden of all-cause and cause-specific mortality due to smokeless tobacco use: Systematic review and meta-analysis, Tob Control, (2016)
[5]  
Vidyasagaran A.L., Siddiqi K., Kanaan M., Use of smokeless tobacco and risk of cardiovascular disease: a systematic review and meta-analysis, Eur J Prev Cardiol, 23, 18, pp. 1970-1981, (2016)
[6]  
Inamdar A.S., Croucher R.E., Chokhandre M.K., Mashyakhy M.H., Marinho V.C., Maternal smokeless tobacco use in pregnancy and adverse health outcomes in newborns: a systematic review, Nicotine Tob Res, 17, 9, pp. 1058-1066, (2015)
[7]  
WHO framework convention on tobacco control, (2003)
[8]  
Gravely S., Giovano G., Craig L., Commar A., D'Espaignet E., Schotte K., Et al., Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study, Lancet, 2, pp. e166-e174, (2017)
[9]  
Siddiqi K., Scammell K., Huque R., Khan A., Baral S., Ali S., Et al., Smokeless tobacco supply chain in South Asia: a comparative analysis using the WHO Framework Convention on Tobacco Control, Nicotine Tob Res, 18, 4, pp. 424-430, (2016)
[10]  
Timberlake D.S., Sami M., Patel S., Thiagarajan S., Badiyan R., Willard S., The debate over weight- versus price-based taxation of snuff in the United States’ state legislatures, J Public Health Policy, 35, 3, pp. 337-350, (2014)